MarketPeel
Insider Trading Intelligence
TG

Tiago Girao

IMVT
CHIEF FINANCIAL OFFICER · IMMUNOVANT, INC. · CIK 0001618670
FILING MIX · LIFETIME63%/37%
BUYS
5
SELLS
3
TOTAL VALUE
$1.31M
COMPANIES
1
ACTIVE SINCE
May 2025
HOLDINGS NOW
257,596
AVG SELL PX
$32.09
TRADE KIND
SHOWING 8 / 8
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 4 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Tiago Girao, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-6.11%+1.44%-7.55%-7.55%
14d1+100.00%-5.85%+3.27%-9.11%-9.11%
30d1+100.00%-8.99%
60d1+0.00%+22.24%+5.41%+16.84%+16.84%
90d1(1 pending)
180d1(1 pending)
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
IMVT · 257,596 shares · as of Jun 26, 2026
073,376146,753220,129293,5052026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2025
2025
2025
2026
2026
FLOW · 5 buys / 3 sellsCOVERAGE · 5 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
IMVT
IMMUNOVANT, INC.
PURCHASE
Chief Financial Officer
10,000$15.90$159.0K257,596Jun 26, 2026Jun 26, 2026View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Financial Officer
10,000283,505Jun 26, 2026Jun 26, 2026View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Financial Officer
10,000$38.46$384.6K247,596Jun 26, 2026Jun 26, 2026View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Financial Officer
25,760$29.62$763.0K247,596Apr 23, 2026Apr 24, 2026View →
IMVT
IMMUNOVANT, INC.
PURCHASEGRANT
Stock grant
64,968273,356Apr 7, 2026Apr 9, 2026View →
IMVT
IMMUNOVANT, INC.
PURCHASEGRANT
Stock grant
94,00294,002Apr 7, 2026Apr 9, 2026View →
IMVT
IMMUNOVANT, INC.
PURCHASEGRANT
Stock grant
208,388208,388May 1, 2025May 5, 2025View →
IMVT
IMMUNOVANT, INC.
PURCHASEGRANT
Stock grant
293,505293,505May 1, 2025May 5, 2025View →
Other insiders · IMVT
Loading peer insiders…
About this filer
CIK 0001618670
ROLE
Chief Financial Officer
PRIMARY
IMVT
COMPANIES
1
ACTIVE SINCE
May 2025
MARKETPEEL · /INSIDER/0001618670DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback